Collaborative Arrangements (Tables)

9 Months Ended

Sep. 30, 2021

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Collaborative Arrangement on Research and Development

During the three and nine months ended September 30, 2021 and 2020, the Company recognized the following amounts in total related to these agreements:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
	(in thousands)
Total research and development expenses incurred under the Original CTX001 JDCA and A&R JDCA	$	58,659	$	28,623	$	147,448	$	66,720
Vertex’s share recognized in research and development expenses in condensed consolidated statement of operations	35,195		14,311		79,590		33,360